What is Ionis Pharmaceuticals's free cash flow?

Ionis Pharmaceuticals (IONS) reported free cash flow of -$814.58M in Q1 2026.

How has Ionis Pharmaceuticals's free cash flow changed year-over-year?

Ionis Pharmaceuticals's free cash flow decreased by 398.7% year-over-year, from -$163.35M to -$814.58M.

What is the long-term trend for Ionis Pharmaceuticals's free cash flow?

Over 3 years (2021 to 2024), Ionis Pharmaceuticals's free cash flow has grown at a 207.2% compound annual growth rate (CAGR), from $18.84M to -$546.23M.

Ionis Pharmaceuticals IONS Free cash flow

Free cash flow at other companies

Eli LillyLLY

$3.01B+1,828%

PfizerPFE

$2.18B+23.0%

Arrowhead ResearchARWR

——

ALN

Alnylam PharmaceuticalsALNY

——

BridgeBio PharmaBBIO

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$246.1M+87.0%

Gross profit$243.1M+86.8%

Operating income-$117.4M+20.0%

Net income-$92.5M+37.0%

EPS (diluted)-$0.56+39.8%

Balance sheet

See full

Cash & equivalents$173.4M-34.4%

Total debt$691.7M+334%

Total equity$491.4M+3.3%

Total assets$3.4B+22.6%

Cash flow

See full

Operating cash flow-$792.8M-426%

CapEx$21.8M+73.0%

Valuation

See full

Market cap$12.25B+159%

Enterprise value$12.77B+175%

P/S11.6×+5.0×

Profitability

See full

Gross margin98.4%-0.2pp

Operating margin-33.3%-11.0pp

Net margin-30.9%-10.5pp

FCF margin-77.4%+35.3pp

Returns & leverage

See full

Return on equity-67.6%-20.3pp

Debt / equity1.4×+1.1×

Current ratio4.1×-5.6×

Where this comes from

Calculated from Ionis Pharmaceuticals’s reported figures.

−$792.8Mnet cash from operating−$21.8Mcapital expenditures=-$814.58M

The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ionis Pharmaceuticals's free cash flow?: Ionis Pharmaceuticals (IONS) reported free cash flow of -$814.58M in Q1 2026.
How has Ionis Pharmaceuticals's free cash flow changed year-over-year?: Ionis Pharmaceuticals's free cash flow decreased by 398.7% year-over-year, from -$163.35M to -$814.58M.
What is the long-term trend for Ionis Pharmaceuticals's free cash flow?: Over 3 years (2021 to 2024), Ionis Pharmaceuticals's free cash flow has grown at a 207.2% compound annual growth rate (CAGR), from $18.84M to -$546.23M.